Fadare Oluwole, Zheng Wenxin
Department of Pathology, Yale University School of Medicine, New Haven, CT 06504, USA.
Virchows Arch. 2005 Nov;447(5):883-7. doi: 10.1007/s00428-005-0030-3. Epub 2005 Aug 9.
Well-differentiated villoglandular adenocarcinoma of the uterine cervix is characterized by an exophytic growth pattern with variably sized papillae that are lined by stratified columnar cells with no more than moderate cytologic atypia. Based on the favorable outcomes in most of the previously reported cases, it has been suggested that some patients with this subtype may be managed conservatively. The case described herein is an otherwise prototypical well-differentiated villoglandular adenocarcinoma but which was associated with a 4.9-mm focus of poorly differentiated carcinoma at its invasive edge. A review of the literature revealed a variety of findings that suggests a need to reassess the potential morphologic and biologic spectrum of this group of tumors. Five of the approximately 89 reported cases were associated with a higher-grade component of the same or a different histologic subtype. At least one patient with apparently stage 1A1 disease was found to have a positive lymph node. Another patient with stage 1B1 disease but no stromal invasion died of her disease following multiple recurrences. Finally, the frequency of lymphovascular invasion and/or lymph node involvement in recent series far exceeds what was found in the two original series. Our case suggests that well-differentiated villoglandular adenocarcinoma is not a diagnosis that should be unequivocally rendered on a small biopsy since other components may be present and the patients may be undertreated. We urge caution when conservative management (cone biopsy alone when margins are negative and there is no lymphovascular invasion) is offered to patients with this tumor since knowledge about its true biologic spectrum appears to still be in evolution.
子宫颈高分化绒毛腺管状腺癌的特征为外生性生长模式,有大小不一的乳头,乳头内衬以分层柱状细胞,细胞学异型性不超过中度。基于大多数既往报道病例的良好预后,有人提出部分该亚型患者可采取保守治疗。本文所述病例在其他方面是典型的高分化绒毛腺管状腺癌,但在其浸润边缘伴有一个4.9毫米的低分化癌灶。文献回顾显示了各种研究结果,提示有必要重新评估这类肿瘤潜在的形态学和生物学谱。在约89例已报道病例中,有5例伴有相同或不同组织学亚型的高级别成分。至少有1例表面为1A1期疾病的患者被发现有淋巴结转移。另1例1B1期疾病但无间质浸润的患者在多次复发后死于该病。最后,近期系列研究中淋巴管浸润和/或淋巴结受累的频率远远超过最初两个系列的研究结果。我们的病例提示,高分化绒毛腺管状腺癌不能仅凭小活检就明确诊断,因为可能存在其他成分,患者可能未得到充分治疗。对于患有这种肿瘤的患者,当提供保守治疗(切缘阴性且无淋巴管浸润时仅行锥形活检)时,我们敦促谨慎行事,因为关于其真正生物学谱的认识似乎仍在不断发展。